Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

24 trials with published results (25%)

Research Maturity

79 completed trials (81% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

6.2%

6 terminated out of 97 trials

Success Rate

92.9%

+6.4% vs benchmark

Late-Stage Pipeline

33%

32 trials in Phase 3/4

Results Transparency

30%

24 of 79 completed with results

Key Signals

24 with results93% success

Data Visualizations

Phase Distribution

84Total
Not Applicable (21)
P 1 (18)
P 2 (13)
P 3 (21)
P 4 (11)

Trial Status

Completed79
Terminated6
Not Yet Recruiting4
Unknown4
Withdrawn2
Recruiting2

Trial Success Rate

92.9%

Benchmark: 86.5%

Based on 79 completed trials

Clinical Trials (97)

Showing 20 of 20 trials
NCT06884280Phase 3Recruiting

Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study

NCT06773975Phase 1Completed

The Effect of an Oral Nutritional Supplement on the Nutritional and Health Outcomes of the Elderly

NCT07532772Completed

Transfusion Practices in Intensive Care Units: a Hungarian Nationwide Survey

NCT02632760Phase 4CompletedPrimary

Intravenous Iron for Treatment of Anaemia Before Cardiac Surgery

NCT07300111Phase 3Not Yet RecruitingPrimary

A Study to Evaluate Efficacy and Safety of QLG1218(Daprodustat) in Chinese Hemodialysis (HD)-Dependent Subjects With Anemia Associated With Chronic Kidney Disease (CKD)

NCT07296146Phase 3Not Yet RecruitingPrimary

Probiotics Against Erythropoietin Resistance in Chronic Kidney Disease Patients.

NCT02801162Not ApplicableTerminated

Evaluation of Accuracy and Precision of a New Arterial Blood Gas Analysis System Blood in Comparison With the Reference Standard

NCT05682326Phase 3CompletedPrimary

Anemia Studies in CKD: Erythropoiesis Via a Novel PHI Daprodustat - Pediatric (ASCEND-P)

NCT00396435Phase 4CompletedPrimary

Correction of Anaemia and Progression of Renal Failure on Transplanted Patients

NCT05681871Phase 4Completed

South African Paediatric Surgical Outcomes Study 2

NCT07008261Recruiting

Robot-assisted Cystectomies With Regard to Blood Loss, Pain and Transfusions.

NCT07004530Not ApplicableNot Yet RecruitingPrimary

the MCCE vs EGD Trial

NCT06973200Completed

Burden of Schistosomiasis and Soil-transmitted Helminth Infections in Schoolchildren in Banfora, Burkina Faso

NCT04640311Phase 1CompletedPrimary

Comparison of Daprodustat Formulations Produced by Two Methods of Manufacture for Bioequivalence and Dissolution in Healthy Participants

NCT06750354Not ApplicableNot Yet RecruitingPrimary

Study on Effect of Papworth Technique in Anemic Asthmatic Pediatrics

NCT03554616Not ApplicableCompleted

Efficacy of Three Novel Bi-treated Long Lasting Insecticidal Nets

NCT06080555Phase 1Completed

Bioequivalence Study of Ferric Carboxymaltose Injection in Participants With Iron Deficiency Anaemia

NCT03409107Phase 3CompletedPrimary

Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)

NCT02876835Phase 3CompletedPrimary

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)

NCT03457701Phase 2CompletedPrimary

Anemia Studies in CKD: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat- Iron (ASCEND: Fe)

Scroll to load more

Research Network

Activity Timeline